Advanced Portfolio Management’s Teva Pharmaceuticals TEVA Stock Holding History

Advanced Portfolio Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-125,000	Closed	-$1.92M	–	49
2025 Q1	$1.92M	Buy	+125,000	New	+$2.23M	3.87%	10
2024 Q4	–	Sell	-190,000	Closed	-$3.42M	–	76
2024 Q3	$3.42M	Buy	+190,000	New	+$3.33M	3.52%	13
2023 Q3	–	Sell	-600,000	Closed	-$4.52M	–	105
2023 Q2	$4.52M	Buy	600,000 +300,000	+100%	+$2.43M	4.12%	8
2023 Q1	$2.65M	Buy	+300,000	New	+$2.97M	2.65%	13

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Advanced Portfolio Management's TEVA Position: Q2 2025 in Review

Advanced Portfolio Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2025, closing a stake of 125,000 shares — an estimated $1.92M sold.

Advanced Portfolio Management first reported a position in TEVA in Q1 2023 and held it in 4 quarters. The position peaked at $4.52M in Q2 2023. 539 funds tracked by Wall St. Rank hold TEVA as of Q2 2025.

Advanced Portfolio Management reported no remaining Teva Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Advanced Portfolio Management sold 125,000 Teva Pharmaceuticals shares in Q2 2025, an estimated $1.92M.
Advanced Portfolio Management first reported a position in Teva Pharmaceuticals in Q1 2023 and held it in 4 quarters.
Advanced Portfolio Management's Teva Pharmaceuticals position peaked at $4.52M in Q2 2023.
539 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2025.

Based on Advanced Portfolio Management's 13F filing for Q2 2025, filed 13 Aug 2025.